These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20384430)

  • 1. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
    Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
    Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggression and disruptive behavior disorders in children and adolescents.
    Turgay A
    Expert Rev Neurother; 2004 Jul; 4(4):623-32. PubMed ID: 15853581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of comorbidity in conduct disorder with attention-deficit hyperactivity disorder (ADHD).
    Turgay A
    Essent Psychopharmacol; 2005; 6(5):277-90. PubMed ID: 16222912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for use of mood stabilizers and anticonvulsants in the treatment of nonaffective disorders in children and adolescents.
    Amaladoss A; Roberts N; Amaladoss F
    Clin Neuropharmacol; 2010; 33(6):303-11. PubMed ID: 21079456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognizing and managing bipolar disorder in children.
    Wozniak J
    J Clin Psychiatry; 2005; 66 Suppl 1():18-23. PubMed ID: 15693748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the pharmacotherapy of aggression in children and adolescents.
    Stewart JT; Myers WC; Burket RC; Lyles WB
    J Am Acad Child Adolesc Psychiatry; 1990 Mar; 29(2):269-77. PubMed ID: 2182611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice.
    Jensen PS; Bhatara VS; Vitiello B; Hoagwood K; Feil M; Burke LB
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):557-65. PubMed ID: 10230187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytics, adrenergic agents, and naltrexone.
    Riddle MA; Bernstein GA; Cook EH; Leonard HL; March JS; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divalproex sodium in the treatment of pediatric psychiatric disorders.
    Rana M; Khanzode L; Karnik N; Saxena K; Chang K; Steiner H
    Expert Rev Neurother; 2005 Mar; 5(2):165-76. PubMed ID: 15853487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior-disordered and aggressive children: new advances in pharmacotherapy.
    Campbell M; Anderson LT; Green WH
    J Dev Behav Pediatr; 1983 Dec; 4(4):265-71. PubMed ID: 6582068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?
    Tsiouris JA
    J Intellect Disabil Res; 2010 Jan; 54(1):1-16. PubMed ID: 20122096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacology of disorders in children.
    Sylvester C
    Psychiatr Clin North Am; 1993 Dec; 16(4):779-91. PubMed ID: 8309812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics.
    Ernst CL; Goldberg JF
    J Clin Psychiatry; 2002; 63 Suppl 4():42-55. PubMed ID: 11913676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.